These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36340303)

  • 21. Are biomarkers of chronic alcohol misuse useful in the assessment of DWI recidivism status?
    Couture S; Brown TG; Tremblay J; Ng Ying Kin NM; Ouimet MC; Nadeau L
    Accid Anal Prev; 2010 Jan; 42(1):307-12. PubMed ID: 19887172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder.
    Vannier AGL; Shay JES; Fomin V; Patel SJ; Schaefer E; Goodman RP; Luther J
    JAMA Netw Open; 2022 May; 5(5):e2213014. PubMed ID: 35594048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review.
    Khan A; Tansel A; White DL; Kayani WT; Bano S; Lindsay J; El-Serag HB; Kanwal F
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):191-202.e1-4; quiz e20. PubMed ID: 26256464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protocolized screening and detection of occult alcohol use before and after liver transplant: Lessons learned from a quality improvement initiative.
    Lim N; Leventhal TM; Thomson MJ; Hassan M; Thompson J; Adams A; Chinnakotla S; Humphreville V; Kandaswamy R; Kirchner V; Pruett TL; Schuller L; McCarty M; Lake J
    Clin Transplant; 2023 Sep; 37(9):e15036. PubMed ID: 37218656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of alcohol use disorders in patients with alcoholic liver disease.
    Addolorato G; Mirijello A; Barrio P; Gual A
    J Hepatol; 2016 Sep; 65(3):618-30. PubMed ID: 27155530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alcohol use disorder and the liver.
    Buchanan R; Sinclair JMA
    Addiction; 2021 May; 116(5):1270-1278. PubMed ID: 32710592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy for alcoholic liver disease.
    Jaurigue MM; Cappell MS
    World J Gastroenterol; 2014 Mar; 20(9):2143-58. PubMed ID: 24605013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphatidylethanol as a sensitive and specific biomarker: comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin.
    Hartmann S; Aradottir S; Graf M; Wiesbeck G; Lesch O; Ramskogler K; Wolfersdorf M; Alling C; Wurst FM
    Addict Biol; 2007 Mar; 12(1):81-4. PubMed ID: 17407500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidisciplinary Care of Alcohol-related Liver Disease and Alcohol Use Disorder: A Narrative Review for Hepatology and Addiction Clinicians.
    Shroff H; Gallagher H
    Clin Ther; 2023 Dec; 45(12):1177-1188. PubMed ID: 37813775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of PEth Compared With Other Alcohol Biomarkers in Subjects Presenting For Occupational and Pre-Employment Medical Examination.
    Neumann J; Beck O; Helander A; Böttcher M
    Alcohol Alcohol; 2020 Jun; 55(4):401-408. PubMed ID: 32363383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lifetime drinking history in patients with alcoholic liver disease and patients with alcohol use disorder without liver disease.
    Nielsen JK; Olafsson S; Bergmann OM; Runarsdottir V; Hansdottir I; Sigurdardottir R; Björnsson ES
    Scand J Gastroenterol; 2017; 52(6-7):762-767. PubMed ID: 28276826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
    Klimas J; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
    Cochrane Database Syst Rev; 2014 Dec; (12):CD009269. PubMed ID: 25470303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated Multidisciplinary Management of Alcohol-associated Liver Disease.
    Holbeck M; DeVries HS; Singal AK
    J Clin Transl Hepatol; 2023 Nov; 11(6):1404-1412. PubMed ID: 37719958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel treatments for alcoholic hepatitis.
    German MN; Musto J; Lucey MR
    Curr Opin Gastroenterol; 2021 May; 37(3):179-186. PubMed ID: 33769374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concentration of fatty acid ethyl esters in hair of alcoholics: comparison to other biological state markers and self reported-ethanol intake.
    Wurst FM; Alexson S; Wolfersdorf M; Bechtel G; Forster S; Alling C; Aradóttir S; Jachau K; Huber P; Allen JP; Auwärter V; Pragst F
    Alcohol Alcohol; 2004; 39(1):33-8. PubMed ID: 14691072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption.
    Staufer K; Andresen H; Vettorazzi E; Tobias N; Nashan B; Sterneck M
    Hepatology; 2011 Nov; 54(5):1640-9. PubMed ID: 21809364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The roles of phosphatidylethanol, ethyl glucuronide, and ethyl sulfate in identifying alcohol consumption among participants in professionals health programs.
    Reisfield GM; Teitelbaum SA; Opie SO; Jones J; Morrison DG; Lewis B
    Drug Test Anal; 2020 Aug; 12(8):1102-1108. PubMed ID: 32309913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Good outcome after liver transplantation for ALD without a 6 months abstinence rule prior to transplantation including post-transplant CDT monitoring for alcohol relapse assessment - a retrospective study.
    Kollmann D; Rasoul-Rockenschaub S; Steiner I; Freundorfer E; Györi GP; Silberhumer G; Soliman T; Berlakovich GA
    Transpl Int; 2016 May; 29(5):559-67. PubMed ID: 26865285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychotherapy for Alcohol Use Disorder Is Associated With Reduced Risk of Incident Alcohol-Associated Liver Disease.
    Vannier AGL; Przybyszewski EM; Shay J; Patel SJ; Schaefer E; Goodman RP; Luther J
    Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1571-1580.e7. PubMed ID: 35964893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating driver risk using alcohol biomarkers, interlock blood alcohol concentration tests and psychometric assessments: initial descriptives.
    Marques P; Tippetts S; Allen J; Javors M; Alling C; Yegles M; Pragst F; Wurst F
    Addiction; 2010 Feb; 105(2):226-39. PubMed ID: 19922520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.